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Maria G. Guzman,@) Gustav0 Kouri,@) Jose Bravo,(‘) Luis Valdes,(*) SusanaVazquez,(‘) 
and Scott B. Halsteadt3) 
Objective: Dengue hemorrhagic fever/dengue shock syndrome (DHF/DSS) is a growing global health problem. 
It is not known how age affects the outcome of secondary dengue infections. In an island setting, a large DHF/DSS 
outbreak in Cuba occurred in 1981. Involved were individuals, 3-40 year old, whose only lifetime dengue exposure 
was to DEN-l in 1977 and DEN-2 in 1981. In this report we calculate age-specific DHF/DSS hospitalization and 
death rates based on secondary DEN 2 infections. 
Methods: Published and unpublished hospital and seroepidemiologic data from the 1981 DHF/DSS outbreak were 
used for the analysis. 
Results: Children, aged 3 and 4 years, with secondary DEN-2 infections were found to have a high death rate 
(25.400 000 secondary DEN-2 infections).The death rate fell with increasing age, being 15.9-fold lower in the 10-14- 
year age group. The death rate for children aged 3-14 years was 14.5-fold higher than in young adults aged 15-39 
years. The death rate rose somewhat in adults aged 50 years and older. DHF/DSS hospitalization rates showed the 
same trend as death rates. 
Conclusions: Age is an important variable in the outcome of secondary DEN-2 infections. DHF/DSS case fatality 
and hospitalization rates are highest in young infants and the elderly. The risk that a child will die during a secondary 
DEN-2 infection is nearly 15-fold higher than the risk in adults. 
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Since the 1960s more than 4 million persons, mostly 
children, have been hospitalized and more than 65 000 
have died of dengue hemorrhagic fever/dengue shock 
syndrome (DHF/DSS). 1,2 During the first two decades, 
epidemics were observed only in children3 an obser- 
vation which led some to speculate that children were 
inherently susceptible and adults were resistant to 
DHF/DSS.‘s4 The possibility that adults might be in- 
susceptible to DHF/DSS has important implications for 
vaccine development and testing. Because of assumed 
safety, adults have been enrolled in phase I vaccine 
trials.5-7 An opportunity to learn how age is related 
to the risk of DHF/DSS was provided by the unique 
epidemiology of dengue in Cuba. In 1977, dengue 
(DEN) 1 virus was transmitted extensively through the 
island.8 Dengue fever had not been reported in Cuba 
since 1943; furthermore, in a 1975 survey, only 2.6% of 
1860 persons in an island-wide sample had dengue 
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hemagglutination-inhibition (HI) antibodies; HI anti- 
bodies were found in persons older than 45 years.8 The 
only clinical syndrome observed in 1977 was dengue 
fever. In 1981, DEN-2 was introduced. The consequent 
epidemic resulted in cases of DHF/DSS and deaths across 
a broad age range.9 Intensive mosquito control reduced 
the number of cases during August, and after October 
1981, no more cases were reported. With comprehensive 
evidence that dengue transmission had stopped, and 
because of the known persistence of dengue antibodies, 
in 1983 a seroepidemiologic study of persons who had 
been infected during the 1977 and 1981 epidemics was 
conducted in a representative ward of urban Havana.‘O 
Although published, these data were not fully exploited 
to assess age as a risk factor for death, or DHF/DSS as 
an outcome of dengue infection, Using demographic 
data, reports on deaths and hospitalizations, together 
with published data, we have calculated age-specific rates 
of death and hospitalization by age among estimated 
secondary DEN-2 infections. 
MATERIALS AND METHODS 
Dengue epidemics 
In 1977, there was a major episode of DEN-l trans- 
mission in Cuba, with more than 0.5 million dengue 
fever cases reported, but, based upon HI antibodies, 
44.5% of the urban population was infected.8 In 1981, 
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DHF/DSS was recognized in late May after the 
beginning of the rainy season. Cases were reported 
simultaneously in three municipalities in the eastern, 
central and western parts of the country. Within a few 
days, the epidemic extended explosively to the rest 
of the country. In total, 344 203 cases were reported; 
approximately 10 000 were classified as severely ill 
(WHO grades I-IV), and there were 158 deaths (101 
children and 57 adults). The highest daily incidence 
occurred on 6 July 1981, when 11400 cases were reported. 
Dengue virus type 2 was isolated. Following an intensive 
vector control campaign, the epidemic ended in October.9 
Once it was recognized as a DHF epidemic, standard- 
ized criteria were established for the diagnosis and 
classification of patients, based on their need for 
hospitalization and different kinds of treatment. Early 
hospitalization and early use of rehydration therapy 
were favored. In order to carry out the therapeutic 
measures selected, boarding schools in all the provinces 
were used as hospitals, and a transportation network for 
the transfer of patients was established. Also, medical 
personnel were redistributed, close supervision of 
activities was maintained, and the necessary organiza- 
tional and operational adjustments were made as the 
epidemic evolved. 9 Standard medical actions were 
established for the whole country. The health system 
in Cuba is free, universal and accessible to everyone, 
independently of the locale and social status of the 
patient. All Cuban provinces and municipalities are 
provided with hospitals and polyclinics. 
Seroepidemiologic studies 
In the absence of dengue transmission anywhere in 
Cuba, a retrospective seroepidemiologic study was con- 
ducted in the Cerro municipality, Havana City, during 
1983.1° Cerro municipality is demographically repre- 
sentative of the densely populated districts of the city, 
with an area of 13.4 km2 and 125 000 inhabitants at 
the time of the study. During the 1981 outbreak, 890 
residents were hospitalized because of dengue, and 
three of them were fatalities.‘O Using the single dilution 
plaque reduction method, the prevalence of neutralizing 
antibodies to dengue 1 and dengue 2 viruses was mea- 
sured in 1945 Cerro residents. That neutralizing anti- 
bodies accurately measure dengue infections in 1977 
and 1981 is supported by the known specificity and long 
persistence of such antibodies.” 
Clinical observations 
During the crisis of the 4-month 1981 dengue epidemic, 
it was not possible for the Ministry of Health to pro- 
mulgate standardized WHO DHF/DSS case definitions 
for use throughout Cuba. Instead, cases in adults and 
children were reported as ‘dengue fever’, ‘dengue severe’ 
and ‘dengue very severe’, the latter two categories being 
roughly equivalent to DHF without shock and DSS, 
respectively. i2 During the epidemic, in all age groups 
there were 10 000 such cases reported.9 A complete 
record (including clinical charts) of all 158 deaths 
was available at the Institute of Tropical Medicine. 
This record contains name, age, sex, address, date 
of hospitalization and date of death of all patients 
receiving a diagnosis of dengue during the epidemic 
(Table 1). I n C b u a, autopsies are performed routinely. 
Autopsy records were available for a large majority of 
fatal dengue cases. Gross and micropathologic findings 
were similar to with those observed in DHF/DSS fatal 
cases in South East Asia.i3 Serologic, virologic and 
PCR studies done in fatal cases in children and adults 
supported dengue virus as the etiologic agent of the 
disease.‘&” 
Published reports from the William Soler Hospital,18 
a 400-bed pediatric teaching hospital, affiliated with the 
Faculty of Medicine, University of Havana, allowed us to 
reconstruct the age distribution of children hospitalized 
with severe dengue syndromes in Havana. This hospital 
provided approximately 30% of all pediatric beds in this 
city in 1981. Data available for analysis were from June, 
July and August 1981 and comprised 85% of total dengue 
admissions. Not included are children aged 2 years and 
younger who were born after DEN-l transmission ended 
and not at risk for secondary DEN-2 infection. The 
age distribution of children hospitalized with dengue; 
severe’ and ‘very severe’ is shown in Table 2. 
Sources of data describing the distribution by 
age and syndromes in adults included medical special- 
ization theses written by postgraduate physicians.19-23 
The most comprehensive of these was obtained from the 
Dr Aldereguia Lima Hospital, a teaching hospital in 
Cienfuegos, a provincial capital, population 200 000, 
located 250 km southeast of Havana (Table 3). 
We knew the total ‘severe’ and; very severe’ dengue 
cases reported in 1981, but, not their distribution by 
locale. An estimate of total cases in Havana children was 
made from cases admitted to William Soler Hospital 
(around 30% of all admissions). In addition, another 
Table 1. Age and sex of persons dying with a clinical diagnosis 
of dengue in Havana and all Cuba, 1981 
Age 
Havana Cuba 
(years) Male Female Male Female 
3-4 4 9 12 14 
5-9 5 12 22 21 
lo-14 3 2 10 13 
15-19 1 0 5 3 
20-24 0 0 2 3 
25-29 1 2 3 6 
30-34 0 1 4 6 
35-39 0 1 2 2 
40-44 0 2 1 3 
45-49 0 1 1 1 
50-54 1 1 3 2 
55-59 1 0 3 0 
60-64 2 2 3 2 
65+ 3 2 4 3 
Totals 21 35 75 79 
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Table 2. Age of DHF/DSS patients admitted to William 5&r 
Hospital, Havana, June-August, 1981l* 
Age (years) 
3 4 
5 
6 
7 
8 
9 
10 
11 
12 
13 
14 
Tota I 
Patients 
45 49 I- 
79 
74 
85 i 
65 
87 
75 
70 
63 1 
78 
72 
842 
% 
11.2 
46.3 
42.5 
Table 3. Age distribution of DHFlDSS Cases in adults during the 
1981 outbreak. Data from Cienfuegos, Hospital Provincial 
Clinico-QuirOrigo-Docente 'Dr. Aldereguia Lima'23 
Age group Female Male Total 
15-19 73 55 128 
20-24 53 27 80 
25-29 45 24 69 
30-34 44 27 71 
35-39 30 30 60 
40-44 16 17 33 
45-49 20 11 31 
50-54 10 7 17 
55-59 10 12 22 
60-64 8 7 15 
65+ 8 5 13 
Total 317 222 539 
% 
23.7 
14.8 
12.8 
13.2 
11.1 
6.1 
5.8 
3.2 
4.1 
2.4 
2.5 
approach was taken that relied on the fact that medical 
services in Cuba reach the whole population and are 
fairly uniform. If it is assumed that case fatality rates in 
and outside Havana were the same, then, since the 39 
deaths in Havana children aged < 1-14 years comprised 
24.68% of total deaths, an estimated 2468 pediatric cases 
occurred in Havana, with 6076 cases nationwide 
(96/158x 10 OOO).The same method was used to estimate 
‘severe’ and ‘very severe’ cases in adults resident in 
Havana and all of Cuba. Thus, 1329 and 3924 adult cases 
were estimated for Havana and all of Cuba, respectively. 
For simplicity, hereafter these cases are described as 
DHF/DSS. 
Statistical studies 
Data were analyzed for statistical significance by the chi- 
square and Mann-Whitney equations. 
RESULTS 
Estimated secondary DEN-2 infections in 
Havana, 1981 
Demographic data for Havana are given in Table 4. As 
measured in 1983, the prevalence of antibodies to both 
DEN-l and DEN-2 among residents of the Cerro 
district, Havana, was 17.6% for all age groups up to 34 
years.lO This is taken as the 1981 secondary DEN 2- 
infection rate and used with some modifications to 
calculate secondary dengue infections in all age groups 
resident in Havana. 
In the Cerro serosurvey, it was observed that the 
prevalence of neutralizing antibodies to DEN-2, but 
only to DEN 2, progressively increased in individuals 
older than 35 years. lo DEN-2 antibodies were found in 
23.1% of persons 15-34 years old, but in 33.1% of 35-44- 
year-olds. All of this increase occurred in persons in the 
40-44 age group (M. G. Guzman,unpublished observa- 
tions). DEN-2 antibody prevalence was 53.4% in the age 
group 45-65+ years. lo This was attributed to dengue 
epidemics reported during or before World War II.8,24,25 
The only dengue virus surmised to be active in that 
era in the Americas was DEN 2. 24, 26 In the older age 
groups, DEN2 immunity reduced the fraction of the 
Table 4. Age-specific DHF/DSS death rates per 10 000 secondary DEN-2 infections, Havana, 1981a 
Age % DEN- Susceptible to 
(vears) Population 2 Susceptible DEN-2 
3, 4 48 780 100 48 780 
5-9 128 148 100 128 148 
10-14 182 951 100 182 951 
15-19 203 777 100 203 777 
20-24 220 815 100 220 815 
25-29 135 678 100 135 678 
30-34 141 515 100 141 515 
35-39 136 530 100 136 530 
40-44 133 594 89.6 119700 
45-49 117892 71.0 83 703 
50-54 100 565 71.0 71 401 
55-59 92 627 71.0 65 765 
60-64 79 029 71.0 56 111 
65+ 197 749 71.0 140 402 
Totals 1 919 650 - 1 735 276 
aDoes not count deaths in children ~3 years. 
“Rate of secondary infections in 3-4-year-old5 is 10.5%; all others 17.6% (see text). 
Secondary 
DEN-2 
infectionsb 
5 122 
22 554 
32 199 
35 865 
38 863 
23 879 
24 907 
24 029 
21 067 
14 732 
12 566 
11575 
9 876 
24711 
301 945 
Deaths 
13 
17 
5 
1 
0 
3 
1 
1 
2 
1 
2 
1 
4 
5 
56 
Deaths1 
104 secondary 
DEN-2 
25.4 
7.5 
1.6 
0.3 
0.0 
1.3 
0.4 
0.4 
0.9 
0.7 
1.6 
0.9 
4.0 
2.0 
Effect of age on outcome of secondary dengue 2 infections I Guzman et al 121 
population susceptible to DEN-2 infections in 1981 
(Table 4). Assuming that adults of all ages were equally 
at risk in the 1977 and 1981 epidemics, the number of 
1981 secondary DEN-2 infections was calculated by 
applying the 17.6% rate to the fraction of each age 
group estimated to be susceptible to DEN-2 (Table 4). 
Infants born in 1979 were not alive for the entire 
period of DEN-l transmission and therefore would not 
expected to be fully at risk to secondary DEN-2 
infections. The measured prevalence of DEN-l and 
DEN-2 neutralizing antibodies of 10.5% in children 
aged 3 and 4 years is consistent with this expectation.1° 
Estimated secondary DEN-2 infections in Cuba, 1981 
Although the 1981 dengue epidemic involved the entire 
country, the prevalence of antibodies to DEN-l and 
DEN-2 infections all over Cuba was not measured. 
Assuming a stable relationship between secondary 
dengue infections and dengue fatalities throughout the 
country, infections should be described by a ratio of 60 
dengue deaths in Havana and 158 in the whole country. 
The secondary DEN-2 infection rate for Cuba can be 
calculated as follows: Havana (rate x 1981 population)/ 
Cuba (rate x 198lpopulation)=60/158; or, 17.6% x 
1 990 OOO/ A x 10 040 000=60/158 (A=9.2%). This rate, 
treated as in Table 4, was used to generate estimates of 
secondary DEN-2 infections by age group in Cuba 
(Table 5). 
From estimated secondary DEN-2 infections, age- 
specific DHF/DSS death and hospitalization rates per 
10 000 secondary DEN-2 infections for Havana and 
Cuba in 1981 are calculated (Tables 4-7). 
DISCUSSION 
The 1981 DEN-2 epidemic in Cuba provided an un- 
paralleled opportunity to measure age as an outcome 
variable in secondary dengue infections in a setting in 
which the genotype of the responsible DEN-2 was 
known.16%27 While the ages of children hospitalized with 
DHF/DSS in Cuba have been published? these had not 
been expressed as age-specific rates. This paper provides 
estimates of 1981 age-specific dengue death and DHF/ 
DSS hospitalization rates for Havana and all Cuba. 
What is unique here is the opportunity to express rates 
relative to the base secondary DEN-2 infections. 
Estimates for death rates among secondary DEN-2 
infections are reasonably hard for Havana. Deaths were 
known by residence of the deceased, and secondary 
DEN-2 infection rates had been measured in a repre- 
sentative sample of the population of Havana.‘O For 
the first time, deaths are presented as age-specific rates 
among persons experiencing secondary DEN-2 infect- 
ions (Tables 4 and 5). 
We attempted to take advantage of the large number 
of deaths reported for the whole country to refine age- 
specific mortality rates. We estimated secondary DEN-2 
infections for all Cuba from the ratio of deaths reported 
for Havana and all Cuba.This estimate, an average 9.2% 
secondary DEN-2 infection rate for all Cuba, is 
consistent with other published data. Dengue-neutral- 
izing antibodies were measured in a large age-stratified 
serum collection made in 1998 in Santiago de Cuba28 
and nearby (50 km) suburban Palma Soriano (M. G. 
Guzman, unpublished observations). The prevalences 
of antibodies to both DEN-l and DEN-2 (secondary 
DEN-2 rate) in persons aged 20-54 years (aged 3-36 
years in 1981) in Santiago and Palma Soriano were 
13.1% (69/525) and 9.4% (13/138), respectively. From 
intensive surveillance of cases and the prevalence of 
DEN-2 antibodies in residents younger than 18 years 
-old, it was concluded that the 1997 DEN-2 epidemic 
involved Santiago but not Palma Soriano. Thus, anti- 
bodies observed in the latter site could only have 
resulted from the 1981 epidemic. As evidence that 9.2% 
Table 5. Age specific DHFlDSS death rates per 10 000 secondary DEN 2 infections. all Cuba, 1981 
Age 
(year+ Population 
DEN-2 
2 Susceptible 
Secondary 
DEN-2 
infections Deaths 
Deaths110 000 
secondary 
DEN-2 
3. 4 298 718 
5-9 800906 
IO-14 1 116251 
15-19 1 183352 
20-24 1061 157 
25-29 713407 
30-34 730054 
35-39 665 588 
40-44 608 161 
45-49 496203 
50-54 419 940 
55-59 366585 
60-64 308628 
65+ 826136 
Totals 9 595084 
298718 
800906 
1116251 
1 183352 
1061157 
713407 
730054 
665 588 
608161 
352043 
298157 
260275 
219 126 
586981 
8894176 
16429 
73683 
102695 
108868 
97626 
65633 
67165 
61234 
52929 
32412 
27430 
23945 
20159 
53963 
804171 
26 
43 
23 
8 
5 
9 
10 
4 
4 
2 
5 
3 
5 
7 
154 
15.8 
5.8 
2.2 
0.7 
0.5 
1.4 
1.5 
0.6 
0.7 
0.6 
1.8 
1.2 
2.5 
1.3 
alnthis series, diagnoses of'dengue' and 'dengue grave'were given to 48 infants less than 1 year, and 19 and 29 children aged 1 and 2 
years, respective1y.R is assumedthatallofthesewere primary DEN-2 infections. 
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Table 6. Estimated age distribution of hospitalized DHF/DSS 
cases and hospitalization rates per 10 000 secondary dengue 
2 infections, Havana and all Cuba, 1981 
Havana Cuba 
Rates/lo4 Rates/lo4 
Age secondary secondary 
Cvears) Cases DEN-Za Cases DEN-2b 
3-4 248 484 611 372 
5-9 1027 455 2526 343 
IO-14 941 292 2319 226 
15-19 315 88 930 85 
20-24 197 51 581 60 
25-29 170 71 502 76 
30-34 175 70 518 77 
35-39 148 62 436 71 
40-44 81 38 239 45 
45-49 77 52 228 70 
50-54 43 34 126 46 
55-59 53 46 161 67 
60-64 37 38 110 55 
65+ 33 13 94 17 
Totals 3545 9381 
aDenominator, see Table 2. bDenominator, see Table 3. 
is a reasonable estimate, it is likely that dengue infection 
rates were higher in cities than in rural areas. Further- 
more, the combined populations of Santiago de Cuba 
and Havana, sites where serologic studies were per- 
formed, comprise approximately 25% of the Cuban 
population. 
DHF/DSS cases, as defined by the WHO, were 
not reported to the Cuban Ministry of Health in 1981. 
Rates in this paper are based upon the diagnoses 
‘dengue severe’ and ‘dengue very severe’. Contributing 
to confidence that in children these categories are equi- 
valent to DHF/DSS are the published clinical observa- 
tions of the 1981 outbreak made by pediatricians.9*15,18,29 
In 1981, there had been few descriptions of DHF/DSS 
in adults, the syndrome having been observed mainly in 
children since its recognition in South East Asia two 
decades earlier.3J3 Accordingly, few Cuban physicians 
who cared for adults had read the dengue literature. 
Therefore, it is possible that ‘severe’ and ‘very severe’ 
diagnoses in adults do not correspond to DHF/DSS. 
However, Diaz et al, in 1988,r7 reported the clinical 
findings on 130 adults, including 26 fatalities admitted 
with hemorrhagic dengue to three of the main hospitals 
in Havana city (Calixto Garcia, Salvador Allende and 
Enrique Cabrera hospitals). All were serologically con- 
firmed, and fatal cases were autopsied. This study 
provided evidence that the clinical characteristics of 
these adult cases were similar to those of DHF/DSS in 
children. 
While age-specific secondary DEN-2 morbidity and 
mortality rates are based upon our best estimates, the 
age differential among fatal cases is real. This study 
establishes a powerful association between age of the 
individual and risk of dying with the vascular perme- 
ability syndrome during a secondary dengue infection. 
Death rates in 3-4-year-old children were as high as 25.4 
per 10 000 secondary DEN-2 infections, nearly three- 
fold higher than in 5-9-year-olds, and nearly five-fold 
greater than in lO--14-year-olds. Thus, age-related case 
fatality rates in dengue are higher in younger than in 
older children, similar to other fluid-losing syndromes 
(Figures 1 and 2). Presumably, secondary infections in 
children less than 3 years old could be still more severe. 
As shown in Table 6, the hospitalization rates for 
DHF/DSS in children during secondary DEN-2 in- 
fections do not decline with age as steeply as do death 
rates. The data in Tables 4-7 provide estimates of the 
frequency of deaths and DHF/DSS during secondary 
DEN-2 infections in children and adults in Havana and 
all Cuba. In Havana, DHF/DSS deaths occurred 14.5 
(5.8/0.4) times more frequently in children than in young 
adults aged 15-39 years. For all Cuba, the child to young 
adult ratio for dengue deaths was 5.3 (4.8jO.9). DHF/ 
DSS attack rates were higher in younger than in older 
adults, but, in older persons, case fatality rates rose 
(Figures 1 and 2). When the ratios of child to adult 
DHF/DSS cases were compared, the differences were 
not as large as those observed in death ratios, 5.4 and 3.8, 
in Havana and ail Cuba, respectively. 
DHF/DSS must be considered a children’s disease, 
because the pediatric age group is innately at increased 
risk compared with adults. Remarkably, the period 
immediately after the end of childhood is the age of the 
lowest intrinsic risk for severe clinical outcome of a 
secondary DEN-2 infection. For adults, an important 
fact, reported elsewhere, i7 is that classical DHF/DSS did 
Table 7. Ratios between DHFlDSS cases and deaths in adults and children in Havana versus Cuba 
Age Secondary 
Group Site DHFIDSS Deaths DEN 2 DHFIIPa DeathsllPb 
3-14 Havana 2216 35 59875 370.1 5.8 
3-14 Cuba 5456 92 192807 282.9 4.8 
15-39 Havana 1005 6 147 543 68.1 0.4 
15-39 Cuba 2967 36 400 526 74.1 0.9 
40-65+ Havana 324 15 94527 34.3 1.6 
40-65+ Cuba 958 26 210838 45.4 1.2 
All adults Havana 1329 21 242070 54.9 0.9 
All adults Cuba 3925 62 611 364 64.2 1.0 
aAll differences between DHF~DSS and death rates per 10 000 secondary DEN-2 infections for children versus younger and older adults and younger 
versus older adults are significant (P<lO-s), except for death rates in Cuba, ages 15-39 versus 40-65+ years. 
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Figure 1. Age-specific DHFlDSS rates per 10 000 secondary dengue 2 infections and case fatality rates in Havana, 1981. 
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Figure 2. Age-specific DHF/DSS death rates per secondary dengue 2 infections and case fatality rates in Cuba, 1981. 
occur, but at a considerably reduced rate compared with ACKNOWLEDGMENTS 
children. Deaths due to dkngue in adults were reliably 
reported in 1981. Of the 158 deaths, 23 were studied 
serologically or virologically and were shown to have 
been associated with a recent dengue infection.15*r6 Also, 
almost all deaths were autopsied. Results from some of 
these cases have been published.14JsJ7 Our data show 
a trend toward higher death rates in individuals 50 
years and older (Figure 2). This phenomenon was also 
reported in the 1928 Greek outbreak, thought to be 
caused by DEN-2. 30*31 Age distributions described in this 
paper are in remarkable accord with recent studies on 
microvascular permeability showing highest values in 
youngest human subjects.32 
We thank Lucia Iturralde for the preparation of this 
manuscript. 
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